Clinical Trial Update: Acamprosate Treatment: Mechanisms of Action [Phase 2]

View source ↗

Summary

A Yale University-sponsored Phase 2 trial evaluated acamprosate for alcoholism and examined its mechanisms of action; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• acamprosate (acamprosate)

Snippet

Sponsor: Yale University | Conditions: Alcoholism | Phase 2 | Status: COMPLETED